My intent was not to say they are going slow and be snarky about it but to say that if the process is slower than expected or desired that taking the time to get it right is not a bad thing and should be done that way. I would much rather them take an extra 1-2 months and get the application right than to rush it and have to do some level of corrections.
I don’t know what comparative autologous therapy was an approved sooner and I don’t care. My statement of preference that they take the time to get shit right is valid.
Management are not going slow. What comparative autologous therapy was approved sooner?
Do you want an entire list, or just a few examples? In the autologous DC cancer vaccine space the only FDA approval took 15 months from data cut (which happens before datalock). Last I checked, NWBO is at 31 months from datalock and no evidence they have even submitted. Oh, and that is with an absurd delay from trial completion until datalock.
I would be more interested in examples of approvals that have taken this long after the pivitol trials was completed to be approved. Alas, I have none.